Approval · Notice of Compliance 3619 · 2003
TRAVATAN: Notice of Compliance 3619
Issued April 8, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3619
- Date
- April 8, 2003
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph update: precautionary information for patients with renal or hepatic impairment
- Therapeutic class
- Elevate intraocular pressure therapy - prostaglandin f2alpha analogue
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRAVATAN | Not yet assigned | — |
Medicinal ingredients
- TRAVOPROST 0.004 PER